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Abstract
Background data There is a considerable difference in
pain perception among individuals. In patients with chronic
pain, recent studies using fMRI, PET and SPECT have
shown that functional changes mainly occurred in the
anterior cingulate cortex (ACC), prefrontal cortex (PFC)
and thalamus. Brain magnetic resonance spectroscopy
(MRS) can evaluate brain chemistry by measuring metab-
olites such as N-acetyl aspartate (NAA). The purpose of
this study was to analyze whether brain MRS could assess
pain due to lumbar spine diseases.
Methods NAA levels were determined relative to the
concentration of creatine/phosphocreatine complex (Cr)
and choline (Cho), which is commonly used as an internal
standard. The NAA/Cr and NAA/Cho ratios in the ACC,
PFC and thalamus were compared between six patients
with unilateral pain (left side) and six control patients
without pain.
Results In the right thalamus (contralateral side to
symptom), the NAA/Cr in the patients with pain was sta-
tistically significantly lower compared with the control
patients (p \ 0.05). Also, in the right thalamus, the NAA/
Cho in pain patients was significantly lower compared with
controls (p \ 0.01). When considering just the right thal-
amus, there were statistically significant correlations
between the numerical rating scale for pain (NRS) and
NAA values.
Conclusions Lumbar pain can be assessed indirectly by
analyzing the decrease in NAA concentration in the
thalamus.
Introduction
Pain is one of the most frequent symptoms in lumbar spine
diseases, as evaluated using a numerical rating scale
(NRS), visual analog scale (VAS) and/or faces pain scale
[1, 2]. However, there is a considerable difference in pain
perception among individuals. Patients with lumbar spine
diseases sometimes complain of severe pain that cannot be
explained by physical findings or imaging studies. If pain is
measured objectively, the pathogenesis of lumbar spine
diseases and/or therapeutic efficacy may be evaluated more
accurately. Thus, when considering that the pain pathway
for objective pain measurement is ultimately recognized in
the brain [3], cerebral imaging and/or metabolic studies can
be useful.
Recent brain imaging such as functional MRI (fMRI)
showed morphological and functional changes in the brain
of patients with chronic pain [4–8]. Single-voxel proton
magnetic resonance spectroscopy (MRS) is a non-invasive
examination determining the cell metabolism of tissues and
organs. A number of studies indicate that MRS can detect
biochemical changes associated with functional brain
abnormalities, such as epilepsy [9], dementia, Parkinson’s
disease, schizophrenia and depression [10]. Grachev and
colleagues [11] have reported that in chronic low back pain
(CLBP) patients, reductions in N-acetyl aspartate (NAA)
and glucose were observed in the prefrontal cortex (PFC).
Recently, Sharma and colleagues [12] showed that NAA
levels in the primary somatosensory cortex decreased in
patients with CLBP. Also, Gussew and colleagues [13]
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demonstrated that reductions in NAA were observed in the
anterior insula and anterior cingulated cortex in patients
with non-specific CLBP.
CLBP pain is the most common cause of employees
missing work for a long period [14]. It has been reported
that CLBP is closely associated with depressive and anxi-
ety states [15], and long-term LBP further exacerbates such
psychiatric conditions [16]. When evaluating pain (LBP
and sciatica) due to lumbar spine diseases using MRS,
patients with a shorter duration of pain and without severe
psychiatric conditions may be good candidates for analysis.
The purpose of this study was to analyze whether MRS in
these patients could assess pain due to lumbar spine
diseases.
Subjects and methods
This study was approved by our institutional review board
(no. 1254), and informed consent was obtained from each
subject and control. Subjects studied included six patients
complaining of unilateral pain (left side) due to lumbar
spine diseases. The numerical rating scale (NRS) showed
symptom severity was most painful during the day because
pain became worse when moving and walking. Subject
gender consisted of two males and four females. Age
ranged from 28 to 68 years old (mean age 40 years). Dis-
eases included two with disc herniation, three with spinal
stenosis and one with idiopathic low back pain. Symptom
duration was from 2 to 12 months (mean duration
5.7 months). Six healthy subjects without pain were used
for control (Table 1). There were no significant differences
in gender and age between the patient and the control
groups. The brief scale for psychiatric problems in ortho-
pedic patients (BS-POP) for medical personnel was used
for evaluating psychiatric states. Verification of reliability,
validity and reproducibility of the BS-POP has already
been confirmed [17].
All MRI and MRS studies were performed with a 3-T
clinical imaging instrument (Achieva 3.0T, Philips, The
Netherlands). High-resolution sagittal and axial views were
used for identification of the anterior cingulated cortex
(ACC), prefrontal cortex (PFC) and thalamus (Fig. 1).
Proton localized spectra were collected using point-
resolved spectroscopy (PRESS). The settings for taking
MRS were TR 2000 ms, TE 36 ms, voxel size
20 mm 9 15 mm 9 15 mm and NSA [number of sample
(signals) averaged] 128. In the current study, we focused
on N-acetyl aspartate (NAA) (Fig. 2). The value of NAA
was measured relative to the concentration of the creatine/
phosphocreatine complex (Cr) and choline (Cho), which is
commonly used as an internal standard [4]. The NAA/Cr
and NAA/Cho ratios in the ACC, PFC and thalamus were
compared between the subjects and the controls. In all
subjects, MRS was taken before treatment with medication
or neuronal blocks.
Statistical analysis
Data were expressed as the mean ± SD. A non-parametric
test (Mann-Whitney U test) was used for comparison
among groups. Pearson’s correlation coefficients were used
to analyze the correlations between NRS and NAA values.
p values \0.05 were considered statistically significant
difference.
Table 1 Summary of subjects
Subjects or control Age Gender Diagnosis Symptom NRS of pain Duration of pain
(months)
BS-POP
Subject 1 68 Female LCS Lt. sciatica 7 12 8
Subject 2 38 Female LDH Lt. LBP and sciatica 6 2 10
Subject 3 38 Female LCS Lt. sciatica 3 8 9
Subject 4 34 Male LDH Lt. sciatica 7 3 10
Subject 5 28 Male Discopathy Lt. LBP 8 2 11
Subject 6 34 Female LCS Lt. LBP and sciatica 4 7 8
Control 1 52 Male – – 0 – –
Control 2 56 Male – – 0 – –
Control 3 24 Male – – 0 – –
Control 4 23 Female – – 0 – –
Control 5 27 Male – – 0 – –
Control 6 69 Female – – 0 – –
LCS lumbar canal stenosis, LDH lumbar disc herniation, LBP low back pain, NRS numerical rating scale for pain, BS-POP brief scale for
psychiatric problems in orthopedic patients
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Results
On the psychiatric states evaluated by the BS-POP, five of
six patients had normal scores, with one patient having an
abnormal borderline score (11 points). Therefore, we
concluded that these patients had no severe psychiatric
problems.
On the NAA/Cr, there were no statistically significant
differences between the two groups in the bilateral ACC,
PFC and left thalamus. However, in the right thalamus
(contralateral side to the symptom), the NAA/Cr in the
subjects (1.29 ± 0.62) was statistically significantly lower
compared with controls (1.54 ± 0.17; p \ 0.05) (Table 2).
On the NAA/Cho, there were also no statistically signifi-
cant differences between the two groups in the bilateral
ACC, PFC and left thalamus. However, in the right thala-
mus (contralateral side to the symptom), the NAA/Cho in
the subjects (1.59 ± 0.097) was statistically significantly
lower compared with controls (1.92 ± 0.16; p \ 0.005)
(Table 3). All NAA/Cr and NAA/Cho data for the
thalamus are shown in Table 4. When the differences
between the right and left side of the NAA/Cr and NAA/
Cho in the thalamus were compared between the subjects
and the control group, only the NAA/Cr ratio was statis-
tically significant different (p \ 0.05).
When focused on the right thalamus, there were statis-
tically significant correlations between the NRS and NAA
values (Fig. 3). In the ACC and PFC, there were no sig-
nificant correlations between the NRS and NAA values.
Fig. 1 Location of the spectroscopic voxel in the brain. a Anterior cingulated cortex (ACC). b Prefrontal cortex (PFC). c Thalamus
Fig. 2 Proton localized spectra. NAA N-acetyl aspartate, Cr creatine/
phosphocreatine complex, Cho choline
Table 2 NAA/Cr compared between subjects and control
Subjects
(mean ± SD)
Control
(mean ± SD)
p value
R ACC 1.313 ± 0.189 1.242 ± 0.134 0.337
L ACC 1.169 ± 0.478 1.355 ? 0.077 0.63
R PFC 1.609 ± 0.252 1.651 ± 0.136 0.873
L PFC 1.526 ± 0.154 1.560 ± 0.136 0.688
R thalamus 1.292 ± 0.062 1.536 ± 0.172 0.025
L thalamus 1.328 ± 0.103 1.439 ± 0.141 0.15
R right, L left, ACC anterior circulated cortex, PFC prefrontal cortex
Table 3 NAA/Cho compared between subjects and control
Subjects
(mean ± SD)
Control
(mean ± SD)
p value
R ACC 1.473 ± 0.244 1.476 ± 0.224 1
L ACC 1.277 ± 0.548 1.497 ± 0.178 0.631
R PFC 2.488 ± 0.465 2.498 ± 0.238 0.522
L PFC 2.274 ± 0.548 2.218 ± 0.264 1
R thalamus 1.586 ± 0.097 1.919 ± 0.163 0.006
L thalamus 1.738 ± 0.239 1.783 ± 0.161 0.81
R right, L left, ACC anterior cingulated cortex, PFC prefrontal cortex
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Discussion
This study demonstrated that the patients with unilateral pain
(LBP and/or sciatica) due to lumbar spine diseases with
shorter duration (within 12 months) of pain and without
severe psychiatric conditions showed decreases in the NAA/
Cr and NAA/Cho in the thalamus on the contralateral side
from the symptom. There were statistically significant cor-
relations between NRS and NAA values. Lumbar pain can
possibly be assessed indirectly by analyzing the decrease in
the NAA concentration in the thalamus.
Recent pain studies using fMRI [6–8], positron emission
tomography (PET) [18, 19] and single-photon emission
computed tomography (SPECT) [20, 21] have shown that
functional changes mainly occurred in the ACC, PFC and
thalamus in patients with chronic pain. PET and fMRI
studies in the healthy subjects demonstrated that acute pain
activated the primary and secondary somatosensory cortex
(S1 and S2), insular cortex, ACC, PFC and thalamus [22].
These areas and the basal ganglia, cerebellum, amygdala,
hippocampus and regions within the parietal and temporal
cortices are often called the ‘‘pain matrix.’’ The matrix can
be thought of as having lateral components (sensory-dis-
criminatory, involving areas such as the primary and sec-
ondary somatosensory cortices, thalamus and posterior
parts of the insula) and medial components (affective-
cognitive-evaluative, involving areas such as the anterior
Fig. 3 Correlation between the NRS and NAA in the thalamus. a Correlation between the NRS and NAA/Cr. b Correlation between the NRS
and NAA/Cho. NRS Numerical rating scale for pain, NAA N-acetyl aspartate, Cr creatine/phosphocreatine complex, Cho choline
Table 4 NAA/Cr and NAA/Cho in the thalamus
Subjects
or
control
NAA/Cr in
the rt.
thalamus
NAA/Cr in
the lt.
thalamus
NAA/Cho in
the rt.
thalamus
NAA/Cho in
the lt.
thalamus
Subject
1
1.34 1.25 1.6 2.03
Subject
2
1.336 1.301 1.721 1.779
Subject
3
1.322 1.231 1.639 1.437
Subject
4
1.19 1.42 1.52 1.79
Subject
5
1.24 1.49 1.44 1.92
Subject
6
1.323 1.278 1.596 1.471
Control
1
1.67 1.35 2.02 1.92
Control
2
1.3 1.27 1.65 1.59
Control
3
1.51 1.46 1.99 1.98
Control
4
1.79 1.66 2.11 1.67
Control
5
1.46 1.53 1.92 1.87
Control
6
1.484 1.364 1.826 1.666
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parts of the insula, ACC and PFC) [23]. The current study
showed NAA reduction only in the contralateral thalamus.
This finding may suggest that the subjects in this study had
little affective-cognitive-evaluative factor associated with
their pain. However, the ‘‘pain matrix’’ is not a definitive
entity because different brain regions play a more or less
active role depending on the precise interplay of the factors
involved in influencing pain perception, for example,
cognition and mood.
In the current study, we used MRS for evaluation of lumbar
pain (LBP and sciatica). An exact correlation between MRS
and other brain imaging is still uncertain [22]. The NAA is
localized within neurons and involved in synaptic processes. It
has been observed to decrease in various conditions involving
neuronal cell damage and loss and is therefore thought to be a
neuronal and axonal marker [11, 22, 24]. CLBP is a multi-
factorial, pathological condition involving psychiatric prob-
lems, which may influence the results of NAA concentration
[25]. In the current study, pain duration was less than
12 months, and the BS-POP was essentially normal. There-
fore, the results of this study may show pain due to lumbar
spine diseases without influence of psychiatric problems.
There is some variability in MRS results. It has been
reported that the NAA concentration and NAA/Cho were
higher in the left thalamus by 21.9 and 20 %, respectively,
in healthy subjects [26]. However, the results of the current
study showed lower NAA/Cr and NAA/Cho in the left
thalamus in the control group (Table 4). The cause is not
clear. Side matching in the same subjects may be important
for proton MRS studies. All of the subjects in the current
preliminary report had left side pain. Regarding the rela-
tionship between age and NAA, Charles et al. [27] reported
that the choline, creatine and NAA were lower in older
subjects in the voxel representing cortical and subcortical
gray matter. Recent studies by Grachev et al. [28, 29]
demonstrated that there was no evidence for NAA corre-
lation strength differences in the thalamus, insula, orbital
frontal cortex and sensorimotor cortex between the young-
aged group and middle-aged group. Regarding the rela-
tionship between gender and NAA, Charles et al. [27] and
Nagae-Poetscher et al. [26] reported that there were no
differences between males and females. Therefore, age
matching may be more important than gender matching for
comparative studies of disease states using proton MRS.
The thalamus plays an important role in the pain pathway.
Every sensory system except for the olfactory system
includes a thalamic nucleus that receives sensory signals and
sends them to the associated primary cortical area (Fig. 4)
[30]. The relation between NAA concentration in the thala-
mus and pain has been previously reported. Pattany and
colleagues [31] showed that the NAA concentration was
negatively correlated with pain intensity in patients with
chronic neuropathic pain after spinal cord injury. Fukui and
colleagues [32] showed a decrease in the NAA concentration
on the contralateral side in seven of nine neuropathic pain
patients. Our study showed similar results using subjects
with a shorter duration of pain. The NAA concentration in
the thalamus may decrease during the acute stage of pain.
However, the relationship among NAA changes, duration of
pain and therapeutic efficacy was not clarified in the current
study. A decrease in thalamic perfusion has been reported in
patients with chronic pain using SPECT [20, 21]. If effective
treatment is not given and the NAA reduction lasts for a long
time, a chronic pain condition may develop in patients with
severe acute pain. Further studies are needed to clarify these
important points.
The current study has several limitations. The number of
patients was very small. Strict age matching and gender
matching were not performed. The symptom duration was
short. The MRI instrument had no linear combination model
(LC model) software that could measure the absolute con-
centration of NAA [33, 34]. We analyzed the NAA concen-
tration in only three brain regions (ACC, PFC and thalamus).
Further studies in more patients with various pain conditions
are needed. In conclusion, lumbar pain in patients with shorter
durations of pain and without severe psychiatric conditions
may be objectively assessed indirectly by analyzing the
decrease in the NAA concentration in the thalamus.
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Fig. 4 Pain pathway. Every sensory system except for the olfactory
system includes a thalamic nucleus that receives sensory signals and
sends them to the associated primary cortical area. S1 Primary
somatosensory cortex, S2 secondary somatosensory cortex, IC insular
cortex (reproduced from [24] with permission)
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